Sale!

CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CERS1 gene, which are implicated in the development of Progressive Myoclonus Epilepsy Type 8 (PME-8). PME-8 is a rare, inherited neurological disorder characterized by a combination of myoclonic seizures (sudden, involuntary muscle jerks) and progressive neurological decline. This condition is part of a group of diseases known as the progressive myoclonus epilepsies, which vary in their cause and genetic background.

The genetic test involves analyzing the patient’s DNA to detect specific mutations in the CERS1 gene that are known to cause PME-8. Early and accurate diagnosis through genetic testing can be crucial for the management of the condition, allowing for tailored treatment plans and genetic counseling for affected families.

The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its expertise in genetic diagnostics and personalized medicine. The cost reflects the complex nature of the genetic analysis and the significant insight it provides into managing a rare and challenging condition like PME-8.

Description

CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test

Test Name: CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test

Components: CERS1 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Referring Doctor: Neurologist

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for CERS1 Gene Progressive Myoclonus Epilepsy Type 8 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with CERS1 Gene Progressive Myoclonus Epilepsy Type 8

Test Details:

The CERS1 gene is associated with a rare genetic disorder called Progressive Myoclonus Epilepsy Type 8 (PME8). PME8 is characterized by progressive muscle jerking or myoclonus, seizures, and cognitive decline.

NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disorder. In the case of PME8, NGS Genetic Testing can be used to analyze the CERS1 gene for any variations or mutations that may be responsible for the development of the disorder.

By identifying specific genetic variations or mutations in the CERS1 gene, NGS Genetic Testing can help in diagnosing PME8 and provide valuable information for the management and treatment of affected individuals. It can also help in identifying carriers of the genetic mutation and provide information for genetic counseling and family planning.

Test Name	CERS1 Gene Progressive myoclonus epilepsy type 8 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CERS1 Gene Progressive myoclonus epilepsy type 8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CERS1 Gene Progressive myoclonus epilepsy type 8
Test Details	The CERS1 gene is associated with a rare genetic disorder called Progressive myoclonus epilepsy type 8 (PME8). PME8 is characterized by progressive muscle jerking or myoclonus, seizures, and cognitive decline. NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disorder. In the case of PME8, NGS Genetic Testing can be used to analyze the CERS1 gene for any variations or mutations that may be responsible for the development of the disorder. By identifying specific genetic variations or mutations in the CERS1 gene, NGS Genetic Testing can help in diagnosing PME8 and provide valuable information for the management and treatment of affected individuals. It can also help in identifying carriers of the genetic mutation and provide information for genetic counseling and family planning.